Novo Nordisk or Eli Lilly? The Billion-Dollar GLP-1 Battle Is Heating Up
The global pharmaceutical industry is witnessing one of the biggest healthcare competitions in history. Two industry giants—Novo Nordisk and Eli Lilly—are …
Obesity Treatment
Novo Nordisk or Eli Lilly? The GLP-1 Battle That’s Reshaping Healthcare
The global market for GLP-1 medicines continues to attract significant attention from patients, healthcare professionals, investors, and pharmaceutical companies. Novo Nordisk …
Generic GLP-1 Drugs Could Change the Weight-Loss Market—FDA Begins Review
The U.S. market for GLP-1 medicines continues to expand rapidly as demand for obesity and diabetes treatments grows. In another important …